Yuanyuan Qin

Yuanyuan Qin

Auto-generated profile, based on publicly available information

Yuanyuan Qin

Department of Pathology and Intelligent Pathology Institute, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2018 in PLOS Biology
Verified
Journal Article
Open access
PDF file
WCWeilong Chen
Weilong Chen
YQYuanyuan Qin
Yuanyuan Qin
DWDong Wang
Dong Wang
LZLei Zhou
Lei Zhou
YLYin Liu
Yin Liu
SLSuling Liu
Suling Liu
Chemotherapeutic resistance in triple-negative breast cancer (TNBC) has brought great challenges to the improvement of patient survival. The mechanisms of taxane chemoresistance in TNBC have not been well investigated. Our results illustrated C-C motif chemokine ligand 20 (CCL20) was significantly elevated during taxane-containing chemotherapy in breast cancer patients with nonpathologic complete response. Furthermore, CCL20 promoted the self-renewal and maintenance of breast cancer stem cells (BCSCs) or breast cancer stem-like cells through protein kinase Cζ (PKCζ) or p38 mitogen-activated protein kinase (MAPK)-mediated activation of p65 nuclear factor kappa B (NF-κB) pathway, significantly increasing the frequency and taxane resistance of BCSCs. Moreover, CCL20-promoted NF-κB activation increased ATP-binding cassette subfamily B member 1 (ABCB1)/multidrug resistance 1 (MDR1) expression, leading to the extracellular efflux of taxane. These results suggested that chemotherapy-induced CCL20 mediated chemoresistance via up-regulating ABCB1. In addition, NF-κB activation increased CCL20 expression, forming a positive feedback loop between NF-κB and CCL20 pathways, which provides sustained impetus for chemoresistance in breast cancer cells. Our results suggest that CCL20 can be a novel predictive marker for taxane response, and the blockade of CCL20 or its downstream pathway might reverse the taxane resistance in breast cancer patients. Breast cancers are divided into several different subtypes according to the expression of three receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal receptor 2 (HER2). One subtype of breast cancer is known as triple-negative breast cancer (TNBC) because of lack of expression of all three receptors. TNBC is highly malignant and susceptible to developing drug resistance during chemotherapy. However, the reasons for resistance have not been well explained. We found that a secretory protein called C-C motif chemokine ligand 20 (CCL20) responds to taxane chemotherapy in TNBC and promotes the expression of a drug efflux pump through a specific signaling pathway (CCL20-protein kinase Cζ [PKCζ]/p38 mitogen-activated protein kinase [MAPK]-nuclear factor kappa B [NF-κB]-ATP-binding cassette subfamily B member 1 [ABCB1]). Increasing levels of CCL20 result in expanding breast cancer stem-like cell population and chemotherapeutic resistance in breast cancer cells. Breast cancer stem-like cells are a special population of cells with self-renewal and differentiation potential within the tumor, which are often the culprit of tumor reoccurrence, drug resistance, and metastasis. Our results suggest that blocking CCL20 or its downstream signal can significantly improve the therapeutic efficacy of TNBC.

3 September 2018 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
WCWeilong Chen
Weilong Chen
YQYuanyuan Qin
Yuanyuan Qin
SLSuling Liu
Suling Liu
Chemotherapy resistance of breast cancer poses a great challenge to the survival of patients. During breast cancer treatment, the development of intrinsic and acquired drug resistance tends to further induce adverse prognosis, such as metastasis. In recent years, the progress of research on cytokine‐modulated tumor microenvironment and breast cancer stem cells (BCSCs) has shed light on defining the mechanisms of drug resistance gradually. In this review, we have discussed cytokine regulation on breast cancer chemoresistance. Cytokines can affect tumor cell behavior or reprogram tumor niche through specific signaling pathways, thereby regulating the progress of drug resistance. In addition, we summarized the mutually regulatory networks between cytokines and BCSCs in mediating chemoresistance. Cytokines in the tumor microenvironment can regulate the self‐renewal and survival of BCSCs in a variety of ways, sequentially promoting chemotherapeutic resistance. Therefore, the combinational treatment of BCSC targeting and cytokine blockade may have a positive effect on the clinical treatment of breast cancer.

1 January 2017 in Theranostics
Verified
Journal Article
Open access
YQYuanyuan Qin
Yuanyuan Qin
WCWeilong Chen
Weilong Chen
BLBingjie Liu
Bingjie Liu
LZLei Zhou
Lei Zhou
LDLu Deng
Lu Deng
CNChaoshi Niu
Chaoshi Niu
We attempt to demonstrate the regulatory role of miR-200c in glioma progression and its mechanisms behind. Here, we show that miR-200c expression was significantly reduced in the glioma tissues compared to paratumor tissues, especially in malignant glioma. Exogenous overexpression of miR-200c inhibited the proliferation and invasion of glioma cells. In addition, the in vivo mouse xenograft model showed that miR-200c inhibited glioma growth and liver metastasis, which is mainly regulated by targeting moesin (MSN). We demonstrated that the expression of MSN in glioma specimens were negatively correlated with miR-200c expression, and MSN overexpression rescued the phenotype about cell proliferation and invasion induced by miR-200c. Moreover, knockdown of MSN was able to mimic the effects induced by miR-200c in glioma cells. These results indicate that miR-200c plays an important role in the regulation of glioma through targeting MSN.

21 February 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
YQYuanyuan Qin
Yuanyuan Qin
WCWeilong Chen
Weilong Chen
GJGuojuan Jiang
Guojuan Jiang
LZLei Zhou
Lei Zhou
XYXiaoli Yang
Xiaoli Yang
SLSuling Liu
Suling Liu
MSN and NONO and their interaction-activated CREB signaling pathway may be new targets for the treatment and prognosis of TNBC.

1 August 2013 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
YQYuanyuan Qin
Yuanyuan Qin
JHJillian L. Hamilton
Jillian L. Hamilton
MBMelanie D. Bird
Melanie D. Bird
MCMichael M. Chen
Michael M. Chen
LRLuis Ramirez
Luis Ramirez
LMLiza Makowski
Liza Makowski
Background Ethanol (EtOH) exposure prior to traumatic injury, such as a burn, elevates systemic and local inflammatory responses and increases morbidity and mortality. Adipose is a large tissue mass that is often inflamed during obesity or other stresses, which disturbs metabolic homeostasis. To date, there has been little investigation into the inflammatory response of adipose tissue after combined EtOH exposure and burn injury. Methods Two EtOH exposure regimens were utilized to examine the role of inflammation in adipose tissue after EtOH and burn injury. Mice were either given a single or episodic binge exposure to EtOH or saline followed by scald (burn) or sham injury 30 minutes later. Twenty‐four hours post injury, serum and adipose tissue were collected for assessment of inflammatory mediators. Results Single binge EtOH alone induced no inflammation in adipose when compared with sham vehicle‐treated mice. However, single binge EtOH followed by burn injury induced significant elevations in mRNA and protein concentrations of pro‐inflammatory mediators interleukin‐6 (IL‐6), KC, and monocyte chemoattractant protein 1 compared with either insult alone or sham vehicle group. Additionally, EtOH exposure and burn injury significantly blunted inducible nitric oxide synthase (iNOS), indicating a complex inflammatory response. Episodic binge EtOH exposure followed by burn injury exacerbated the postburn adipose inflammatory response. The magnitude of the episodic binge‐induced inflammatory parameters postburn were 2‐ to 5‐fold greater than the response detected after a single exposure of EtOH, indicating EtOH‐induced potentiation of burn‐induced inflammatory response. Finally, inflammatory loci and crown‐like structures in adipose were significantly increased by episodic binge EtOH and burn injury. Conclusions This is the first report of binge and burn‐induced crown‐like structure formation. Evidence presented herein suggests an important role for alcohol and burn as an additional mediator of adipose inflammation in postburn injury, a common complication in burn patients.

20 June 2025 in Science Advances
Verified
Journal Article
Open access
WCWeilong Chen
Weilong Chen
YQYuanyuan Qin
Yuanyuan Qin
LQLibo Qiao
Libo Qiao
XLXue Liu
Xue Liu
CGChenyun Gao
Chenyun Gao
XBXiu-Wu Bian
Xiu-Wu Bian
Elevated levels of asparagine, catalyzed by asparagine synthetase (ASNS), have been identified as a prerequisite for lung metastasis in breast cancer. However, the roles and regulatory mechanisms of ASNS in breast cancer brain metastasis (BCBM) are not well understood. Our study revealed that the family with sequence similarity 50 member A (FAM50A) gene substantially modulates the brain metastatic potential of breast cancer by up-regulating ASNS and promoting asparagine biosynthesis. We demonstrated that FAM50A forms a complex with chromosome 9 open reading frame 78 (C9ORF78), specifically at the S121 residue, to enhance ASNS transcription. This interaction accelerates the rate of ASNS-mediated asparagine synthesis, which is essential in facilitating metastatic cascades to the brain. From a therapeutic perspective, both the genetic suppression of FAM50A and pharmacological inhibition of asparagine synthesis effectively counteract BCBM. Our results highlight the importance of the FAM50A-ASNS signaling pathway in BCBM therapy.